Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III

被引:21
|
作者
Horinishi, A
Okubo, M
Tang, NLS
Hui, J
To, KF
Mabuchi, T
Okada, T
Mabuchi, H
Murase, T
机构
[1] Okinaka Mem Inst Med Res, Dept Endocrinol & Metab, Minato Ku, Tokyo 1058470, Japan
[2] Toranomon Gen Hosp, Minato Ku, Tokyo 1058470, Japan
[3] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Pediat, Fac Med, Hong Kong, Hong Kong, Peoples R China
[5] Kanazawa Univ, Sch Med, Dept Internal Med 2, Kanazawa, Ishikawa 920, Japan
关键词
glycogen storage disease type III; glycogen-debranching enzyme; AGL; nonsense mutation; splicing; haplotype; recurrent mutation;
D O I
10.1007/s100380200000
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Glycogen storage disease type III (GSD III) is a rare autosomal recessive inherited disorder caused by a deficiency of the glycogen-debranching enzyme (AGL). We investigated two GSD III patients and identified four different mutations. Nucleotide sequence analysis revealed patient 1 of Chinese descent to be a compound heterozygote for a novel nonsense mutation, R34X, and the splicing mutation (IVS32-12A > G) reported in a Japanese patient. Patient 2 of Japanese origin was found to be compound heterozygous for a novel nonsense mutation, Y1148X, and the splicing mutation (IVS14+1G > T) that we had described previously. To determine whether splicing mutations occurred independently, we performed intense AGL haplotype analysis using 21 intragenic polymorphic markers plus a novel polymorphism IVS32 - 97 A/G in the vicinity of the IVS32 splicing mutation. Patient 1 of Chinese origin and the Japanese patient homozygous for the IVS32 - 12A > G were found to have different haplotypes, indicating the IVS32 - 12A > G mutation to be a recurrent mutation. This is the first recurrent mutation established by intense haplotyping in the AGL gene.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 50 条
  • [31] A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease
    Cheng, Alan
    Zhang, Mei
    Gentry, Matthew S.
    Worby, Carolyn A.
    Dixon, Jack E.
    Saltiel, Alan R.
    GENES & DEVELOPMENT, 2007, 21 (19) : 2399 - 2409
  • [32] Cross-sectional retrospective study of muscle function in patients with glycogen storage disease type III
    Decostre, Valerie
    Laforet, Pascal
    Nadaj-Pakleza, Aleksandra
    De Antonio, Marie
    Leveugle, Sylvain
    Ollivier, Gwenn
    Canal, Aurelie
    Kachetel, Kahina
    Petit, Francois
    Eymard, Bruno
    Behin, Anthony
    Wahbi, Karim
    Labrune, Philippe
    Hogrel, Jean-Yves
    NEUROMUSCULAR DISORDERS, 2016, 26 (09) : 584 - 592
  • [33] Prenatal diagnosis and carrier detection for glycogen storage disease type III using polymorphic DNA markers
    Shen, JJ
    Liu, HM
    McConkie-Rosell, A
    Chen, YT
    PRENATAL DIAGNOSIS, 1998, 18 (01) : 61 - 64
  • [34] Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId
    Endo, Yoriko
    Fateen, Ekram
    El Shabrawy, Mortada
    Aoyama, Yoshiko
    Ebara, Tetsu
    Murase, Toshio
    Podskarbi, Teodor
    Shin, Yoon S.
    Okubo, Minoru
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (10) : 1233 - 1238
  • [35] Glycogen storage disease type III: a mixed-methods study to assess the burden of disease
    Evins, Ayla
    Mayhew, Jill
    Cimms, Tricia
    Whyte, Julie
    Vong, Kathy
    Hribal, Elizabeth
    Evans, Christopher J.
    Grimm, Andrew
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2024, 15
  • [36] Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease
    Shaiu, WL
    Kishnani, PS
    Shen, JJ
    Liu, HM
    Chen, YT
    MOLECULAR GENETICS AND METABOLISM, 2000, 69 (01) : 16 - 23
  • [37] The Novel Compound Heterozygous Mutations in the AGL Gene in a Chinese Family With Adult Late-Onset Glycogen Storage Disease Type IIIa
    Qu, Qianqian
    Qian, Qi
    Shi, Jiejing
    Liu, Haiyan
    Zhang, Yan
    Cui, Wenhao
    Chen, Ping
    Lv, Haidong
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [38] In vivo characterization of glycogen storage disease type III in a mouse model using glycoNOE MRI
    Zeng, Qing
    Machado, Michael
    Bie, Chongxue
    van Zijl, Peter C. M.
    Malvar, Sofi
    Li, Yuguo
    D'souza, Valentina
    Poon, Kirsten Achilles
    Grimm, Andrew
    Yadav, Nirbhay N.
    MAGNETIC RESONANCE IN MEDICINE, 2024, 91 (03) : 1115 - 1121
  • [39] Novel AGL variants in a patient with glycogen storage disease type IIIb and pulmonary hypertension caused by pulmonary veno-occlusive disease: A case report
    Shindo, Akito
    Ueda, Kazutaka
    Minatsuki, Shun
    Nakayama, Yukiteru
    Hatsuse, Satoshi
    Fujita, Kanna
    Nomura, Seitaro
    Hatano, Masaru
    Takeda, Norifumi
    Akazawa, Hiroshi
    Komuro, Issei
    FRONTIERS IN GENETICS, 2023, 14
  • [40] Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III
    Sun, Baodong
    Fredrickson, Keri
    Austin, Stephanie
    Tolun, Adviye A.
    Thurberg, Beth L.
    Kraus, William E.
    Bali, Deeksha
    Chen, Yuan-Tsong
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : 145 - 147